Tenet Healthcare Corp
NYSE:THC

Watchlist Manager
Tenet Healthcare Corp Logo
Tenet Healthcare Corp
NYSE:THC
Watchlist
Price: 203.72 USD 6.55% Market Closed
Market Cap: $17.5B

Wall St Price Targets

THC Price Targets Summary
Tenet Healthcare Corp

Wall Street analysts forecast THC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for THC is 243.8 USD with a low forecast of 175.18 USD and a high forecast of 302.4 USD.

Lowest Forecast
Price Target
175.18 USD
14% Downside
Average Forecast
Price Target
243.8 USD
20% Upside
Highest Forecast
Price Target
302.4 USD
48% Upside
Tenet Healthcare Corp Competitors:
Price Targets
FILA
FILA Fabbrica Italiana Lapis ed Affini SpA
44% Upside
FCL
FINEOS Corporation Holdings PLC
46% Upside

Revenue
Forecast

7% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

7% / Year
Past Growth
-17% / Year
Estimated Growth
Estimates Accuracy
62%
Average Beat
7% / Year
Past Growth
-17% / Year
Estimated Growth
Estimates Accuracy
62%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is -17%.

Operating Income
Forecast

13% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
13% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 1%.

Pre-Tax Income
Forecast

18% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
18% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 4%.

Net Income
Forecast

19% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss
19% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is THC's stock price target?
Price Target
243.8 USD

According to Wall Street analysts, the average 1-year price target for THC is 243.8 USD with a low forecast of 175.18 USD and a high forecast of 302.4 USD.

What is the Revenue forecast for Tenet Healthcare Corp?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for Tenet Healthcare Corp?
Projected CAGR
-17%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is -17%.

What is the Operating Income forecast for Tenet Healthcare Corp?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 1%.

What is the Pre-Tax Income forecast for Tenet Healthcare Corp?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 4%.

What is the Net Income forecast for Tenet Healthcare Corp?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett